40
C AN AD I AN JO U RN AL O F AN ESTH ESIA
she had no history of hepatic or biliary disease and no
clinical findings to suggest that this may have been the
case. It is possible that in previous reports the absorp-
tion of dye may have occurred over a brief period of
time, producing in effect an intravenous bolus of dye,
whereas in the present case absorption may have con-
tinued over a more prolonged period of time.
isosulfan blue dye into the breast for sentinel lymph
node mapping. The most likely explanation for this
change is absorption of dye into the circulation from
the injection site. Arterial blood gases showed PaO2 and
SaO2 consistent with the oxygen delivery, confirming
the suspicion that the pulse oximeter was delivering
falsely low readings. H owever, when intraoperative
desaturation occurs, it is important to rule out possible
causes of desaturation such as pneumothorax, bron-
chospasm or endotracheal tube malpositioning. The
duration of the effect on SpO2 in this patient was
greater than six hours, much longer than the five min-
utes duration reported by Coleman et al.6 following iso-
sulfan blue injection into the cervix. Data from the
present case and others reported in the literature3,5,6
indicate that, following dye injection for lymphatic
mapping, the magnitude and duration of effect on
SpO2 are highly variable.
The value of sentinel node biopsy in predicting axil-
lary disease in patients with carcinoma of the breast is
uncertain. A multicentre NSABP (National Surgical
Adjuvant Breast and Bowel Project) study is underway
to evaluate this. If the sensitivity and specificity of sen-
tinel node biopsy prove to be high, it is not unreason-
able to expect that most axillary node dissections will be
replaced by sentinel node biopsies. Therefore, the type
of incident described in this report will probably
become increasingly common. H owever, the frequency
with which decreased SpO2 occurs following injection
of isosulfan blue into the breast has not been reported.
Finally, although dye absorption may be suspected as
the cause of an intraoperative decrease in SpO2, it is
important to rule out causes of real arterial hypoxemia.
In the case reported here, checking the FI O2 displayed
on the Ohmeda 5250 gas analyzer and the O2 analyzer
on the anaesthesia machine did not indicate delivery of a
hypoxic gas mixture. Increasing the FI O2 to 1.0 to rule
out delivery of a hypoxic gas mixture could also be con-
sidered, although this was not done in the case reported
here. Integrity of the anesthetic breathing circuit should
be checked. Inadvertent endobronchial intubation
should be ruled out by checking for bilateral breath
sounds and verifying that the endotracheal tube is appro-
priately positioned. A suction catheter can be passed
down the tube to rule out kinking or obstruction.
Pneumothorax should be ruled out by checking for
equal air entry bilaterally, absence of tracheal deviation,
and absence of hyperresonance on percussion of the
chest. Chest X-ray can be performed if necessary. If
pneumothorax is suspected, administration of nitrous
oxide should be discontinued and, if tension pneumoth-
orax is suspected, needle decompression of the affected
hemithorax should be performed immediately. Breath
sounds should be auscultated for expiratory wheeze or
prolongation of the expiratory phase, and peak inspira-
tory pressure and shape of the expired CO2 waveform
should be checked to rule out bronchospasm. Causes of
ventilation-perfusion mismatch such as atelectasis or pul-
monary edema must be ruled out. The pulse oximeter
probe may be replaced or moved to another site on the
patient to rule out probe malfunction or poor sensing
due to local hypoperfusion or vasoconstriction.
Addendum
During revision of this case report, another incident of
intraoperative desaturation following administration of iso-
sulfan blue for axillary sentinel node mapping was
observed in another hospital. The SpO decreased from
2
99% to 89% despite increasing inspired O from 40% to
2
100%. Aterial blood gas analysis with co-oximetry was
available at this hospital, and showed a PaO of 449 mm
2
Hg and methemoglobin, expressed as a fraction of total
hemoglobin, of 0.005 (normal range 0 to 0.020). This
demonstrates that co-oximetry was able to rule out methe-
moglobinemia as a cause of decreased SpO in this patient.
2
References
1 Scheller, MS, Unger RJ, Kelner MJ. Effects of intra-
venously administered dyes on pulse oximetry readings.
Anesthesiology 1986; 65: 550–2.
2 Kessler MR, Eide T, Humayun B, Poppers PJ. Spurious
pulse oximeter desaturation with methylene blue injec-
tion. Anesthesiology 1986; 65: 435–6.
3 McEwan, D, Lam K. Oximetry and patent blue five
dye (Letter). Anaesth Intensive Care 1997; 25: 587–8.
4 Saito S, Fukura H, Shimada H, Fujita T. Prolonged
interference of blue dye “patent blue” with pulse oxime-
try readings. Acta Anaesthesiol Scand 1995; 39: 268–9.
5 Morell RC, Heyneker T, Kashtan HI, Ruppe C. False
desaturation due to intradermal patent blue five dye.
Anesthesiology 1993; 78: 363–4.
6 Coleman RL, Whitten CW, O’Boyle J, Sidhu B.
Unexplained decrease in measured oxygen saturation by
pulse oximetry following injection of Lymphazurin 1%
(isosulfan blue) during a lymphatic mapping procedure.
J Surg Oncol 1999; 70: 126–9.
In summary, a case is presented in which intraopera-
tive decrease in SpO2 occurred following injection of